Naxagolide free base
Code | Size | Price |
---|
TAR-T20156-50mg | 50mg | £770.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20156-100mg | 100mg | £1,203.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Naxagolide is a sustained release formulation. It is a dopamine agonist.
CAS:
88058-88-2
Formula:
C15H21NO2
Molecular Weight:
247.338
Purity:
0.98
SMILES:
[H][C@@]12CCc3ccc(O)cc3[C@@]1([H])OCCN2CCC
References
1. Payer D, Balasubramaniam G, Boileau I. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:4-8. doi: 10.1016/j.pnpbp.2013.08.012. Epub 2013 Aug 30. Review. PubMed PMID: 23999545.
2. Iversen L, Foster AC, Hill RG, Iversen SD, Kemp JA, Leeson PD, Rupniak NM, Saywell K, Tricklebank MD, Williams BJ. Neurotoxin-related research: from the laboratory to the clinic. Ann N Y Acad Sci. 1992 May 11;648:207-18. Review. PubMed PMID: 1353328.
3. Goetz CG, Diederich NJ. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May;10(2):527-40. Review. PubMed PMID: 1350052.
4. Obeso JA, Luquin MR, Vaamonde J, Grandas F, Pastor MA, Artieda J, Mart?nez-Lage JM. [Continuous dopaminergic stimulation in Parkinson disease]. Neurologia. 1987 Sep-Oct;2(5):227-34. Review. Spanish. PubMed PMID: 2908545.